Although the relevance of our data to the clinical setting requires further investigation, they provide compelling evidence for the identification of HMGA1 as a novel nuclear activator of FoxO1 gene transcription, which may help explaining noted differences in diabetes phenotypes. Here, FOXO1 is linked to diabetes mellitus.